发明授权
- 专利标题： Treatment for CD5+ B cell lymphoma
- 专利标题（中）： 治疗CD5 + B细胞淋巴瘤
-
申请号： US12173719申请日： 2008-07-15
-
公开(公告)号： US07923429B2公开(公告)日： 2011-04-12
- 发明人: Richard L. Miller , David E. Spaner
- 申请人： Richard L. Miller , David E. Spaner
- 申请人地址： US MN St. Paul
- 专利权人： 3M Innovative Properties Company
- 当前专利权人： 3M Innovative Properties Company
- 当前专利权人地址： US MN St. Paul
- 主分类号： A01N61/00
- IPC分类号： A01N61/00 ; A61K45/00
摘要：
The present invention provides methods for increasing expression of cell surface molecules of CD5+ B cell lymphoma cells by contacting cells with immune response modifiers. The invention also provides methods for the treatment of CD5+ B cell lymphomas, including chronic lymphocytic leukemia and small lymphocytic lymphoma, by administering immune response modifier compounds to a subject in need of such treatment. Suitable immune response modifier compounds include agonists of TLR7 and/or TLR8.
公开/授权文献
- US20090017076A1 TREATMENT FOR CD5+ B CELL LYMPHOMA 公开/授权日：2009-01-15
信息查询
